Wednesday, January 17, 2018

Japanese Drug Co Astellas Pharma Inc With a Stock Market Cap of US$26 Bil Had 31% of Its 2017 Total Sales to US Customers and a Huge 41% of Its 2017 Total Non-Current Assets Located in the US ..... Astellas Pharma Should Benefit From the US Trump Tax Bill

From Astellas Pharma's 2017 Annual Report